Oxolife, a biotech company specializing in female fertility, has announced promising results from a Phase 2 clinical trial of its non-hormonal fertility pill, OXO-001, at the European Society of Human Reproduction and Embryology (ESHRE) 40th Annual Meeting in Amsterdam. The data indicates that OXO-001 significantly improves embryo implantation, pregnancy, and live birth rates in women undergoing in-vitro fertilization (IVF) and intracytoplasmic sperm…
Mira, a hormonal health company providing at-home reproductive health solutions, launches an online Hormone Health Clinic for Fertility aimed to help people – struggling to conceive. The clinic provides personalized support from fertility professionals throughout the conception journey, focusing on addressing hormonal imbalances, streamline nutrition and gut health, setting up effective exercise routines and improving mental health. 1 in 5 people in the US are affected by…
Gynaecological health startup Daye has announced the launch of a comprehensive gynaecological health consultation and pharmacy service. This new service aims to provide women with faster access to healthcare, offering advice, diagnosis, and prescriptions. Specialist nurses, vetted and NHS-trained with over 20 years of experience, will offer in-depth, personalized advice on period pain, vaginal and sexual health, fertility, and menopause. This service…
Clarius Mobile Health has received FDA clearance for its Clarius OB AI fetal biometric measurement tool, which aims to improve access to obstetrical prenatal monitoring and care, especially in resource-limited areas. The Clarius OB AI model, now available with the Clarius C3 HD3 wireless handheld ultrasound scanner in the United States and Canada, automates fetal biometry measurements to estimate fetal age, weight,…
Progyny, a provider of fertility, family building, and women’s health benefits, has announced its strategic acquisition of Apryl, a Berlin-based fertility benefits platform established in 2019. This move bolsters Progyny’s global offerings, providing enhanced guided, concierge support to employees worldwide as they navigate the complexities of fertility and family building care. Progyny’s comprehensive global benefits solution already supports multinational employers and their…
OCON Therapeutics has announced the successful completion of a $10 million investment round led by RH Capital. This funding will enhance OCON’s efforts to develop treatments for prevalent uterine pathologies using its proprietary 3D drug delivery system. The company focuses on developing drug delivery systems to address significant issues in women’s health. The company’s 3D stent drug delivery frame, IUB, has been…
In recognition of Men’s Health Month, Posterity Health has launched its Hormone Management Program across the United States. This program aims to address the issue of low testosterone (Low-T) among American males using best practice clinical protocols to ensure effective and personalized treatment. Low testosterone is a condition affecting over 3 million men in the U.S., with symptoms such as fatigue, poor…
Wisp, a company working in sexual and reproductive health, has taken a step forward by launching a new fertility vertical aimed at supporting women through every stage of their reproductive health journey. Through this strategic move Wisp wants to make healthcare more affordable and accessible for women, especially those facing challenges in conceiving. Fertility is a crucial aspect of women’s reproductive health,…
